Casdin Capital, LLC 13D and 13G filings for BioLife Solutions, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-04-09 5:13 pm Purchase |
2025-04-07 | 13D | BioLife Solutions, Inc. BLFS |
Casdin Capital, LLC | 8,735,159 18.500% |
27,994![]() (+0.32%) |
Filing |
2023-10-24 4:29 pm Purchase |
2023-10-19 | 13D | BioLife Solutions, Inc. BLFS |
Casdin Capital, LLC | 8,707,165 19.500% |
1,267,058![]() (+17.03%) |
Filing |
2020-11-27 5:21 pm Purchase |
2020-11-24 | 13D | BioLife Solutions, Inc. BLFS |
Casdin Capital, LLC | 7,440,107 22.700% |
3,066,774![]() (+70.12%) |
Filing |
2020-05-18 6:15 pm Purchase |
2020-05-14 | 13G | BioLife Solutions, Inc. BLFS |
Casdin Capital, LLC | 4,373,333 18.200% |
1,904,762![]() (+77.16%) |
Filing |